Global Glucose 6 phosphate Dehydrogenase Gene Mutation Detection Kit Market Size By Type (Early Screening, Diagnosis), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Glucose 6 Phosphate Dehydrogenase (G6PD) Gene Mutation Detection Kit Market was valued at USD 420 million in 2023 and is projected to surpass USD 820 million by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031.

The increasing prevalence of G6PD deficiency, rising awareness about genetic disorders, and growing advancements in molecular diagnostics are significantly contributing to market growth. The early detection of G6PD gene mutations plays a critical role in preventing severe health complications like hemolytic anemia, especially in newborns. Furthermore, government initiatives to promote genetic screening and technological innovations in diagnostic kits are anticipated to fuel market expansion.

Drivers:

Rising Prevalence of G6PD Deficiency:

The global burden of G6PD deficiency, particularly in regions like Africa, Asia-Pacific, and the Middle East, is a major driver for the market. The increasing demand for early diagnostic tools to manage and prevent related complications is accelerating market growth.

Technological Advancements in Genetic Testing:

Innovations in molecular diagnostics, such as real-time PCR, CRISPR-based detection, and next-generation sequencing, are improving the accuracy and speed of G6PD mutation detection kits, boosting their adoption across healthcare settings.

Government Initiatives for Newborn Screening:

Several governments and healthcare organizations worldwide are implementing newborn screening programs for genetic disorders, including G6PD deficiency, thereby driving the demand for advanced detection kits.

Restraints:

High Cost of Genetic Testing Kits:

The high initial cost of advanced genetic testing kits may limit market penetration, particularly in low- and middle-income countries, thereby posing a restraint to market growth.

Limited Awareness in Rural Areas:

Lack of awareness regarding G6PD deficiency and the importance of early diagnosis in certain regions remains a challenge for market expansion.

Opportunity:

Expanding Market in Emerging Economies:

Emerging countries in Asia-Pacific, Latin America, and Africa present substantial opportunities due to growing healthcare infrastructure, increasing investments in diagnostic testing, and rising public health awareness.

Integration of AI-based Diagnostic Solutions:

The integration of artificial intelligence in genetic testing can enhance diagnostic accuracy and automate data interpretation, creating new growth avenues for market players.

Market by System Type Insights:

Based on system type, the PCR-based G6PD Mutation Detection Kits segment accounted for the largest market share in 2023. PCR-based kits offer high sensitivity and specificity in detecting G6PD mutations and remain the preferred choice in clinical and research settings.

Meanwhile, CRISPR-based G6PD Mutation Detection Kits are expected to witness the highest growth rate during the forecast period due to their potential for rapid, cost-effective, and precise mutation detection.

Market by End-Use Insights:

In terms of end-use, Hospitals & Clinics dominated the market in 2023, accounting for over 40% of the market share. The growing adoption of genetic testing for newborn screening and patient diagnostics in hospital settings is driving this segment.

The Research & Academic Institutes segment is anticipated to experience significant growth due to increasing research activities focused on genetic mutation analysis and the development of personalized medicine.

Market by Regional Insights:

Asia-Pacific dominated the global G6PD Gene Mutation Detection Kit Market in 2023, attributed to the high prevalence of G6PD deficiency in countries like China, India, and Southeast Asian nations. The region’s large patient population, coupled with rising awareness and government-led screening programs, supports market leadership.

North America is expected to register notable growth due to technological advancements and the increasing adoption of genetic testing in clinical practice. Europe also holds a considerable market share, supported by robust healthcare infrastructure and research activities.

Competitive Scenario:

Key players operating in the global G6PD Gene Mutation Detection Kit Market include Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Abbott Laboratories, Roche Diagnostics, DiaCarta Inc., Seegene Inc., Amoy Diagnostics Co., Ltd., and Genefinity Biotechnology.

These companies are focusing on product innovation, strategic collaborations, and geographical expansion to strengthen their market positions.

Key Market Developments:

In 2023, Thermo Fisher Scientific launched an advanced multiplex PCR kit for rapid detection of G6PD gene mutations, enhancing its diagnostic portfolio.

In 2022, PerkinElmer Inc. partnered with a leading Asian healthcare provider to implement newborn G6PD screening programs across multiple hospitals.

In 2024, Roche Diagnostics announced the development of AI-powered genetic testing platforms, aimed at improving the accuracy of mutation detection in clinical settings.

Scope of Work – Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market

Report Metric Details

Market Size (2023) USD 420 million

Projected Market Size (2031) USD 820 million

CAGR (2023-2031) 8.7%

Key Segments by System Type PCR-based Kits, CRISPR-based Kits

Key Segments by End-Use Hospitals & Clinics, Research & Academic Institutes

Leading Region Asia-Pacific

Key Players Thermo Fisher Scientific, PerkinElmer Inc., Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Seegene Inc., Amoy Diagnostics

FAQs:

1. What is the current market size of the Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market?

The market was valued at USD 420 million in 2023.

2. What is the major growth driver of the Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market?

The major growth driver is the rising prevalence of G6PD deficiency and increasing demand for early diagnostic solutions.

3. Which is the largest region during the forecast period in the Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market?

Asia-Pacific is expected to remain the largest region due to high disease prevalence and supportive government screening programs.

4. Which segment accounted for the largest market share in the Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market?

The PCR-based Detection Kits segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Glucose 6 Phosphate Dehydrogenase Gene Mutation Detection Kit Market?

Key market players include Thermo Fisher Scientific, PerkinElmer Inc., Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, DiaCarta Inc., Seegene Inc., Amoy Diagnostics Co., Ltd., and Genefinity Biotechnology.

Would you like me to prepare a fully formatted Word document version of this report for download?